JAZZ Debt / Equity | Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc (JAZZ) Debt / Equity

2026-06-30: Debt/Equity Ratio 0.91.
2026-03-31: Debt/Equity Ratio 1.18.
2025-12-31: Debt/Equity Ratio 1.24.
2025-09-30: Debt/Equity Ratio 1.35.

Complete source-backed debt/equity ratio history.

Available history: 2011-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Debt/Equity Ratio

Date	Debt/Equity Ratio
2026-06-30	0.91
2026-03-31	1.18
2025-12-31	1.24
2025-09-30	1.35
2025-06-30	1.45
2025-03-31	1.29
2024-12-31	1.49
2024-09-30	1.47
2024-06-30	1.52
2024-03-31	1.54
2023-12-31	1.53
2023-09-30	1.64
2023-06-30	1.62
2023-03-31	1.72
2022-12-31	1.86
2022-09-30	2.09
2022-06-30	1.88
2022-03-31	1.67
2021-12-31	1.53
2021-09-30	1.59
2021-06-30	1.63
2021-03-31	0.55
2020-12-31	0.57
2020-09-30	0.62
2020-06-30	0.67
2020-03-31	0.57
2019-12-31	0.52
2019-09-30	0.53
2019-06-30	0.54
2019-03-31	0.59
2018-12-31	0.58
2018-09-30	0.53
2018-06-30	0.55
2018-03-31	0.57
2017-12-31	0.58
2017-09-30	0.64
2017-06-30	0.76
2017-03-31	0.95
2016-12-31	1.08
2016-09-30	1.19
2016-06-30	0.65
2016-03-31	0.69
2015-12-31	0.7
2015-09-30	0.82
2015-06-30	0.94
2015-03-31	1.03
2014-12-31	0.98
2014-09-30	1
2014-06-30	0.93
2014-03-31	0.96
2013-12-31	0.42
2013-09-30	0.44
2013-06-30	0.47
2013-03-31	0.39
2012-12-31	0.41
2012-09-30	0.52
2012-06-30	0.56
2011-12-31	0

Annual Debt/Equity Ratio

Date	Debt/Equity Ratio
2025-12-31	1.24
2024-12-31	1.49
2023-12-31	1.53
2022-12-31	1.86
2021-12-31	1.53
2020-12-31	0.57
2019-12-31	0.52
2018-12-31	0.58
2017-12-31	0.58
2016-12-31	1.08
2015-12-31	0.74
2014-12-31	0.98
2013-12-31	0.42
2012-12-31	0.41
2011-12-31	0

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
CORCEPT THERAPEUTICS INC (CORT)	United States	$12.804B	169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)	United States	$11.879B	151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)	United States	$11.859B	-38.17
Elanco Animal Health Inc (ELAN)	United States	$11.177B	-61.80
Viatris Inc (VTRS)	United States	$20.008B	-0.00
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28